Form S-3 Karyopharm Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Karyopharm Therapeutics (KPTI) files for 8.84M share offering by selling stockholders
May 4, 2026 4:41 PM EDTKaryopharm Therapeutics (NASDAQ: KPTI) has filed for up to 8,843,036 share offering by selling stockholders.
... MoreKaryopharm Therapeutics (KPTI) files $400M mixed shelf
May 4, 2026 4:38 PM EDTKaryopharm Therapeutics (NASDAQ: KPTI) has filed $400,000,000 mixed shelf of:
Debt Securities
Common Stock
Preferred Stock
Units
Warrants
... More